StockData
Alpha Teknova, Inc. logo

Alpha Teknova, Inc. (TKNO) stock

TKNONasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/30150% above fair value
$8.29−0.32 (-3.77%)

Close on Nov 12, 2026Market cap $445.34MP/E –Yield –

Alpha Teknova operating margin

Operating margin is operating income as a percentage of revenue.

Alpha Teknova's operating margin for the twelve months ending Sep 30, 2026 was -32.7%. For fiscal 2025 it was -41.9%, against -69.3% the year before. The highest annual figure on record is 14.9% in fiscal 2020.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-41.9%+27.4
FY2024Dec 31, 2024-69.3%+27.7
FY2023Dec 31, 2023-96.9%+22.9
FY2022Dec 31, 2022-119.9%−87.3
FY2021Dec 31, 2021-32.5%−47.4
FY2020Dec 31, 202014.9%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-25.2%+13.2
Q2 FY2026Jun 30, 2026-23.7%+9.2
Q1 FY2026Mar 31, 2026-38.8%+11.9
Q4 FY2025Dec 31, 2025-46.2%+14.6
Q3 FY2025Sep 30, 2025-38.4%+39.2
Q2 FY2025Jun 30, 2025-32.9%+20.1
Q1 FY2025Mar 31, 2025-50.7%+35.3
Q4 FY2024Dec 31, 2024-60.7%+77.3
Q3 FY2024Sep 30, 2024-77.6%+29.6
Q2 FY2024Jun 30, 2024-53.0%+7.7
Q1 FY2024Mar 31, 2024-86.0%+12.1
Q4 FY2023Dec 31, 2023-138.0%+42.4
Q3 FY2023Sep 30, 2023-107.3%+107.4
Q2 FY2023Jun 30, 2023-60.7%−4.0
Q1 FY2023Mar 31, 2023-98.1%−45.7
Q4 FY2022Dec 31, 2022-180.4%−133.3
Q3 FY2022Sep 30, 2022-214.7%−173.3
Q2 FY2022Jun 30, 2022-56.7%−26.3
Q1 FY2022Mar 31, 2022-52.4%−43.3
Q4 FY2021Dec 31, 2021-47.2%−55.0
Q3 FY2021Sep 30, 2021-41.4%−65.4
Q2 FY2021Jun 30, 2021-30.4%−42.0
Q1 FY2021Mar 31, 2021-9.1%–
Q4 FY2020Dec 31, 20207.8%–
Q3 FY2020Sep 30, 202024.0%–
Q2 FY2020Jun 30, 202011.6%–

More Alpha Teknova figures

See a number that looks wrong?